Skip to main content
Premium Trial:

Request an Annual Quote

Protagen Obtains ISO Certification

NEW YORK (GenomeWeb) – German autoimmune diagnostics firm Protagen today said that it has received ISO 13485 certification and it now complies with the internationally recognized quality standard for medical devices. 

The certification covers the development, production, and distribution of in vitro diagnostics for autoimmune diseases and indicates that Protagen has implemented a quality management system that conforms to the standard for medical device and diagnostic manufacturing. 

The company had previously obtained ISO 9001 certification. Based in Dortmund, Germany, Protagen develops diagnostic and companion diagnostic tests. Its proprietary SeroTag biomarker platform uses Luminex xMAP technology to identify disease-specific autoantibodies in a highly multiplexed fashion. 

The Scan

Less Than Half

An effort to reproduce key findings from high-profile preclinical cancer studies finds less than half could be replicated, according to the Scientist.

Still Some SARS-CoV-2 Sequencing Holes

The Wall Street Journal reports that viral genomic surveillance has improved in the US, though says there are still gaps.

Avoiding Passing Them On

People with known disease-linked genetic variants are turning to in vitro fertilization so as to not pass those variants to their children, the Washington Post says.

PNAS Papers on Long Cell-Free DNA in Maternal Plasma, Genetic Propensity for Voting

In PNAS this week: long, cell-free DNA of maternal and fetal origins identified in maternal plasma, and more.